Get the Weekly Intelligence Brief — top committee picks every Sunday.
CHD · NYSE · STOCK

Church & Dwight (CHD) Stock Analysis

Consumer Defensive Updated August 25, 2026
$102.49
52W $81.33 – $106.04
60/100
$24.28B
32.8
0.47
AI Committee Verdict
Buy
60/100
Conviction: Contested · 50% agreement · 6 analysts
+0.2%
-1.5%
0.16:1
Contested
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.

Is CHD Bullish or Bearish?

Bullish. Innellis AI committee rates Church & Dwight (CHD) Buy with a composite score of 60/100 , based on 6 analysts with 50% agreement. Last updated August 25, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +15.39 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -4.61 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull & Bear Case

Bull Case
  • ROE of 17.8% shows genuine earnings power backing the valuation — Value
  • EPS growing 46.6% YoY — Growth
  • News sentiment is positive (+0.47 across 15 articles, 14d) — News
Bear Case
  • P/E of 32.3 is moderate-to-rich — Value
  • Price-to-book of 5.0x prices in significant intangible value — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 25, 2026
Overall Committee Score
60/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 36%
of 72 Consumer Defensive peers
Value Analyst neutral
48 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 17.8% shows genuine earnings power backing the valuation
− P/E of 32.3 is moderate-to-rich
Growth Analyst neutral
53 / 100 · High confidence
Moderate growth -- present but not remarkable
+ EPS growing 46.6% YoY
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst bullish
70 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
73 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.47 across 15 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3063.01)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 59.6 to 59.6.

Comparing 2026-08-24 to 2026-08-25 (1 day apart).

Technical Analysis

RSI (14)
62.6
Neutral
MACD Histogram
-0.276
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Support
$100.91
Resistance
$102.75
Bollinger %B
0.71
Inside Bands
Price vs Moving Averages
EMA 9
$100.11 Above
EMA 21
$100.00 Above
EMA 50
$98.91 Above
EMA 200
$96.22 Above

Fundamental Analysis

Valuation
55
Growth
44
Profitability
75
Financial Health
63
Cash Flow
70
Valuation
P/E Ratio 32.8×
P/B Ratio 5.58×
PEG Ratio 0.72
Dividend Yield 1.19%
52W High $106.04
52W Low $81.33
Quality & Growth
ROE 1841.0%
ROA 826.7%
Gross Margin 4564.9%
Operating Margin 1746.6%
Revenue Growth YoY
Debt / Equity 0.56
AI Fundamental Assessment
P/E ratio of 32.8 (rich relative to a 15-40x range); Price-to-book of 5.6x; PEG ratio of 0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 18.4%; Return on assets of 8.3%; Net margin of 12.0%; Gross margin of 45.6%; Current ratio of 1.15 (tight short-term liquidity); Debt-to-equity of 0.56; Free cash flow per share is positive (4.71); Most recent quarter missed estimates by 1.7%; EPS growth decelerating (+10.5% -> -6.3% QoQ); Average YoY EPS growth of -5.3%; Analyst estimates rising over recent quarters
Get the Full CHD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime